Submitted by Anonymous (not verified) on 19 September 2024 - 13:54
Opinion/decision on a Paediatric investigation plan (PIP): Upstaza, Eladocagene exuparvovec, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neurology, PIP number: P/0075/2023
Source: